Responses
Clinical care/Education/Nutrition
Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter study
Compose a Response to This Article
Other responses
No responses have been published for this article.